Prosecution Insights
Last updated: October 02, 2026
Application No. 17/493,281

MICROFABRICATED CORE WIRE FOR AN INTRAVASCULAR DEVICE

Non-Final OA §112
Filed
Oct 04, 2021
Priority
Oct 05, 2020 — provisional 63/087,411
Examiner
PATEL, OM
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Scientia Vascular LLC
OA Round
4 (Non-Final)
59%
Grant Probability
Moderate
4-5
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
68 granted / 116 resolved
-11.4% vs TC avg
Strong +55% interview lift
Without
With
+54.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
39 currently pending
Career history
148
Total Applications
across all art units

Statute-Specific Performance

§101
9.2%
-30.8% vs TC avg
§103
57.0%
+17.0% vs TC avg
§102
12.3%
-27.7% vs TC avg
§112
20.9%
-19.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 116 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on July 22, 2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-5 and 17-19 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “each ribbon having a width that is equal to a diameter of the ribbons” in lines 7-8, but it is unclear what is meant by this as ribbon 204 appears to be rectangular or square and lacks a true diameter. Treating the diagonal as a diameter is geometrically invalid, because the diagonal (hypotenuse) of a rectangle or square is always longer than its width or side length. Hence, the diagonal/diameter of the ribbon can never equal the width, and therefore, no art is found. Claim 1 also recites “each ribbon extending across the full diameter of the ribbons to which it connects”, in lines 8-9, but ribbon 204 does not extend to any ribbons, but rather extends between two disks 202. Furthermore, as discussed above, it is invalid to recite “full diameter of the ribbons” as the ribbons are rectangular or square and lack a true diameter. Therefore, the indefiniteness issues within the claim render a proper prior art search unable to be performed. Claims 2-5 and 17-19 are rejected by virtue of their dependence from claim 1. Conclusion A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Om A. Patel whose telephone number is (571)272-6331. The examiner can normally be reached Monday - Friday 8 a.m. - 5 p.m.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached on (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /OM PATEL/Examiner, Art Unit 3791 /ETSUB D BERHANU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 5 earlier events
Jan 22, 2026
Final Rejection mailed — §112
Mar 12, 2026
Interview Requested
Mar 20, 2026
Response after Non-Final Action
Jul 22, 2026
Request for Continued Examination
Jul 24, 2026
Response after Non-Final Action
Aug 17, 2026
Non-Final Rejection mailed — §112
Sep 29, 2026
Examiner Interview Summary
Sep 29, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740706
MEDICAL IMPLANT WITH WIRELESS COMMUNICATION
6y 2m to grant Granted Sep 22, 2026
Patent 12678061
APPARATUS, METHOD, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM HAVING STORED THEREIN PROGRAM FOR BLOOD PRESSURE ESTIMATING PROGRAM
4y 7m to grant Granted Jul 14, 2026
Patent 12642442
System and Method for Cardiovascular Monitoring and Reporting
2y 7m to grant Granted Jun 02, 2026
Patent 12605095
BLOOD COLLECTION ASSEMBLY
3y 4m to grant Granted Apr 21, 2026
Patent 12594061
URINALYSIS DEVICE AND HEALTH FACILITATION SYSTEM
3y 11m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
59%
Grant Probability
99%
With Interview (+54.6%)
3y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 116 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month